Ubs Group Ag Champions Oncology, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 1,279 shares of CSBR stock, worth $10,116. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,279

Previous 379 237.47%

Holding current value

$10,116

Previous $1,000 500.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.95 - $5.14 $3,555 - $4,626	900 Added 237.47%	1,279 $6,000
Q2 2024 Aug 13, 2024	SELL	$4.5 - $5.23 $3,276 - $3,807	-728 Reduced 65.76%	379 $1,000
Q1 2024 May 13, 2024	SELL	$4.9 - $6.91 $5,497 - $7,753	-1,122 Reduced 50.34%	1,107 $5,000
Q4 2023 Feb 09, 2024	SELL	$4.56 - $6.59 $4,090 - $5,911	-897 Reduced 28.69%	2,229 $12,000
Q3 2023 Nov 09, 2023	BUY	$5.2 - $7.32 $16,255 - $22,882	3,126 New	3,126 $19,000
Q2 2022 Aug 10, 2022	SELL	$6.81 - $8.31 $6,959 - $8,492	-1,022 Reduced 33.82%	2,000 $16,000
Q1 2022 May 16, 2022	BUY	$7.26 - $8.53 $19,906 - $23,389	2,742 Added 979.29%	3,022 $24,000
Q4 2021 Feb 14, 2022	BUY	$7.76 - $10.23 $2,172 - $2,864	280 New	280 $2,000
Q3 2021 Nov 15, 2021	SELL	$9.11 - $10.96 $692 - $832	-76 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$8.45 - $11.72 $20,930 - $29,030	-2,477 Reduced 97.02%	76 $1,000
Q1 2021 May 12, 2021	BUY	$10.61 - $13.75 $16,891 - $21,890	1,592 Added 165.66%	2,553 $29,000
Q4 2020 Feb 11, 2021	SELL	$8.39 - $13.27 $6,124 - $9,687	-730 Reduced 43.17%	961 $10,000
Q3 2020 Nov 12, 2020	SELL	$7.05 - $10.2 $11,005 - $15,922	-1,561 Reduced 48.0%	1,691 $16,000
Q2 2020 Jul 31, 2020	BUY	$6.65 - $9.84 $21,625 - $31,999	3,252 New	3,252 $31,000
Q1 2020 May 01, 2020	SELL	$4.19 - $8.62 $5,857 - $12,050	-1,398 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.12 - $8.33 $7,157 - $11,645	1,398 New	1,398 $12,000
Q3 2019 Nov 14, 2019	SELL	$5.4 - $8.99 $1,215 - $2,022	-225 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$7.51 - $10.12 $1,689 - $2,277	225 New	225 $2,000
Q1 2019 May 14, 2019	SELL	$7.89 - $12.23 $2,903 - $4,500	-368 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$7.29 - $15.27 $31,434 - $65,844	-4,312 Reduced 92.14%	368 $3,000
Q3 2018 Nov 14, 2018	BUY	$5.82 - $17.47 $17,983 - $53,982	3,090 Added 194.34%	4,680 $82,000
Q2 2018 Aug 14, 2018	BUY	$3.6 - $7.27 $2,289 - $4,623	636 Added 66.67%	1,590 $10,000
Q1 2018 May 15, 2018	BUY	$3.39 - $4.39 $3,234 - $4,188	954 New	954 $3,000
Q3 2017 Nov 14, 2017	SELL	$3.03 - $3.97 $16,634 - $21,795	-5,490 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	1,223 Added 28.66%	5,490 $14,000
Q1 2017 Nov 14, 2017	BUY	N/A	4,267	4,267 $14,000

Others Institutions Holding CSBR

# of Institutions

Shares Held

5.82M

Call Options Held

Put Options Held

15K

View Full List

About CHAMPIONS ONCOLOGY, INC.

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $107M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

More about CSBR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account